The Facilitators
We invite you to gain in-depth understanding from leading experts on the application of state-of-the-art proteomic technologies to your life-sciences research. Further academic and facility facilitators TBC.
Prof Brian Searle
Brian is an Assistant Professor at the Mayo Clinic in Rochester, Minnesota, and a co-founder of Proteome Software. His current research focuses on making and validating peptide and protein detections with tandem mass spectrometry and statistically assessing the quality of quantitative proteomics data.
PD Dr Ute Distler
A research associate at the Institute for Immunology, Mainz University, Ute manages the core facility for mass spectrometry with a research focus on developing, optimising and applying methods for quantitative proteome analysis. Ute’s has research interests in method development for DIA-based proteomics, neuroproteomics, and interactomics.
Prof Bernhard Kuster
Full Professor at TUM and principal investigator of the German Cancer Consortium DKTK, with a research focus on proteomics and precision medicine. and questions relating to the molecular mechanisms of therapeutic drugs and cancer for clinical treatment.
Dr Lars Juhl Jensen
Director at ZS Discovery, Lars has developed methods for protein function prediction, visualization of microbial genomes, pattern recognition in promoter regions, and microarray analysis, as well as implementing tools for text mining, integration of omics data, and network analysis. ZS Discovery helps clients innovate innovate novel therapeutics & accelerate drug development to create breakthrough science, reinventing phara discovery.
Prof Jesper V Olsen
Professor and Deputy Head of the Novo Nordisk Centre for Protein Research at the University of Copenhagen. The Olsen group has a long-standing interest in applying their proteomics technology developments to systems-wide analyses of dynamic post-translational modifications such as site-specific phosphorylation that regulate essentially all cellular signal transduction pathways. Jesper was recently awarded the Distinguished Achievement in Proteomic Sciences Award from the Human Proteome Organization at HUPO 2026 in Singapore.
Tony Wu
Anthony (Tony) Wu is a doctoral research student at the Khoury College of Computer Sciences at Northeastern University, in the group of Prof Olga Vitek. His doctoral research focuses on developing computational methods to interpret the results of mass spectrometry-based proteomics and metabolomics experiments, more specifically, developing methods to better integrate mass spectrometry-based readouts with biological networks text-mined from PubMed literature.
Dr Renã Robinson
The RASR Laboratory based at Vanderbilt University uses proteomics to further the understanding of aging and age-related diseases, with a particluar interest in the molecular basis for ethnic and racial disparaties in aging. The lab specializes in developing novel high-throughput applications for analyzing complex biological tissues, increasing sample multipexing capabilities, and studying oxidate post-translational modifications. The also have an interest in high-throughput lipidomics methods for human biofluids.
Prof Kathryn Lilley
The Lilley Group focuses on the development and application of technologies which enable the measurement of the dynamic proteome in space and time in cells in a high-throughput manner. More specifically, we are interested in looking at the changes in abundance, location, interacting partners, post-translational modification status and structure of proteins during dynamic cellular processes such as differentiation. We also develop methods to determine the subcellular distribution of the transcriptome and how this changes upon perturbation, and the complement of proteins that form dynamic ribonuclear complexes.
Dr Stoyan Stoychev
Stoyan is a principal scientist at Evosep. Evosep aims to improve the throughput of liquid chromatography to enable clinical proteomics applications. Through collaborations with world-leading scientists we work to develop new technologies and solutions to make sample separation 10 times faster and 100 times more robust than todays’ alternatives.
Dr Previn Naicker
Previn is the Head of Proteomics at ReSyn Biosciences, bringing extensive expertise in biochemistry, mass spectrometry, and proteomics research. ReSyn Bio focuses on the development of innovative automated sample preparation technologies using magnetic beads. Previn was previously the head of a core proteomics facility and now leads the development and application of cutting-edge proteomics workflows for high-throughput research applications requiring mass spectrometry.
Dr Nicolai Bache
Nicolai Bache is the Chief Strategic Officer and co-founder of Evosep Biosystems, with extensive experience in mass spectrometry, proteomics, and life sciences technology development. Since co-founding Evosep in 2016, he has played a key role in advancing high-throughput, robust, and standardized proteomics workflows. In his current role, he leads Evosep’s long-term strategic direction, fostering innovation and partnerships to accelerate the adoption of proteomics in clinical research and precision medicine.
Dr Jarrod Sandow
Co-Founder and Chief Product Officer of IonOpticks, a biotechnology company specialising in advanced chromatography solutions for proteomics and mass spectrometry, Jarrod has over 20 years of experience in proteomics technology development and commercialisation. At IonOpticks, Jarrod leads product strategy and innovation, focusing on developing high-performance chromatography technologies to accelerate scientific discovery and advance human health research.